141 related articles for article (PubMed ID: 8163272)
1. MIC2 analysis in pediatric lymphomas and leukemias.
Riopel M; Dickman PS; Link MP; Perlman EJ
Hum Pathol; 1994 Apr; 25(4):396-9. PubMed ID: 8163272
[TBL] [Abstract][Full Text] [Related]
2. MIC2, TdT, bcl-2, and CD34 expression in paraffin-embedded high-grade lymphoma/acute lymphoblastic leukemia distinguishes between distinct clinicopathologic entities.
Soslow RA; Bhargava V; Warnke RA
Hum Pathol; 1997 Oct; 28(10):1158-65. PubMed ID: 9343323
[TBL] [Abstract][Full Text] [Related]
3. Ewing's sarcoma--routine diagnostic utilization of MIC2 analysis: a Pediatric Oncology Group/Children's Cancer Group Intergroup Study.
Perlman EJ; Dickman PS; Askin FB; Grier HE; Miser JS; Link MP
Hum Pathol; 1994 Mar; 25(3):304-7. PubMed ID: 8150461
[TBL] [Abstract][Full Text] [Related]
4. Immunocytochemical study of 12E7 in small round-cell tumours of childhood: an assessment of its sensitivity and specificity.
Ramani P; Rampling D; Link M
Histopathology; 1993 Dec; 23(6):557-61. PubMed ID: 8314240
[TBL] [Abstract][Full Text] [Related]
5. MIC2 detection in tumors of bone and adjacent soft tissues.
Devaney K; Abbondanzo SL; Shekitka KM; Wolov RB; Sweet DE
Clin Orthop Relat Res; 1995 Jan; (310):176-87. PubMed ID: 7641436
[TBL] [Abstract][Full Text] [Related]
6. MIC2 analysis of small cell carcinoma.
Lumadue JA; Askin FB; Perlman EJ
Am J Clin Pathol; 1994 Nov; 102(5):692-4. PubMed ID: 7524308
[TBL] [Abstract][Full Text] [Related]
7. MIC2 is a specific marker for Ewing's sarcoma and peripheral primitive neuroectodermal tumors. Evidence for a common histogenesis of Ewing's sarcoma and peripheral primitive neuroectodermal tumors from MIC2 expression and specific chromosome aberration.
Ambros IM; Ambros PF; Strehl S; Kovar H; Gadner H; Salzer-Kuntschik M
Cancer; 1991 Apr; 67(7):1886-93. PubMed ID: 1848471
[TBL] [Abstract][Full Text] [Related]
8. Immunoreactivity of MIC2 (CD99) and terminal deoxynucleotidyl transferase in bone marrow clot and core specimens of acute myeloid leukemias and myelodysplastic syndromes.
Kang LC; Dunphy CH
Arch Pathol Lab Med; 2006 Feb; 130(2):153-7. PubMed ID: 16454553
[TBL] [Abstract][Full Text] [Related]
9. Immunoreactivity of MIC2 (CD99) in acute myelogenous leukemia and related diseases.
Zhang PJ; Barcos M; Stewart CC; Block AW; Sait S; Brooks JJ
Mod Pathol; 2000 Apr; 13(4):452-8. PubMed ID: 10786814
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical analysis of Ewing's sarcoma cell surface antigen p30/32MIC2.
Fellinger EJ; Garin-Chesa P; Triche TJ; Huvos AG; Rettig WJ
Am J Pathol; 1991 Aug; 139(2):317-25. PubMed ID: 1867320
[TBL] [Abstract][Full Text] [Related]
11. FLI1 and MIC2 expression in precursor B-lymphoblastic leukemia with Burkitt-like morphology and extensive extramedullary involvement: A diagnostic challenge in pediatric small round cell tumor.
Das N; Thakral D; Singh G; Malhotra A; Phulware RH; Gogia A; Gupta R
Indian J Pathol Microbiol; 2019; 62(4):614-617. PubMed ID: 31611454
[TBL] [Abstract][Full Text] [Related]
12. Primary cutaneous Ewing's family sarcoma. Report of a case with immunostaining for glycoprotein p30/32 mic2.
Sexton CW; White WL
Am J Dermatopathol; 1996 Dec; 18(6):601-5. PubMed ID: 8989933
[TBL] [Abstract][Full Text] [Related]
13. Small cell osteosarcoma of bone: an immunohistochemical study with differential diagnostic considerations.
Devaney K; Vinh TN; Sweet DE
Hum Pathol; 1993 Nov; 24(11):1211-25. PubMed ID: 7503935
[TBL] [Abstract][Full Text] [Related]
14. Olfactory neuroblastoma and other round cell lesions of the sinonasal region.
Devaney K; Wenig BM; Abbondanzo SL
Mod Pathol; 1996 Jun; 9(6):658-63. PubMed ID: 8782204
[TBL] [Abstract][Full Text] [Related]
15. 013 (CD99) positivity in hematologic proliferations correlates with TdT positivity.
Robertson PB; Neiman RS; Worapongpaiboon S; John K; Orazi A
Mod Pathol; 1997 Apr; 10(4):277-82. PubMed ID: 9110287
[TBL] [Abstract][Full Text] [Related]
16. Precursor B-Lymphoblastic lymphoma presenting as a solitary bone tumor and mimicking Ewing's sarcoma: a report of four cases and review of the literature.
Ozdemirli M; Fanburg-Smith JC; Hartmann DP; Shad AT; Lage JM; Magrath IT; Azumi N; Harris NL; Cossman J; Jaffe ES
Am J Surg Pathol; 1998 Jul; 22(7):795-804. PubMed ID: 9669342
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometric assessment of human MIC2 expression in bone marrow, thymus, and peripheral blood.
Dworzak MN; Fritsch G; Buchinger P; Fleischer C; Printz D; Zellner A; Schöllhammer A; Steiner G; Ambros PF; Gadner H
Blood; 1994 Jan; 83(2):415-25. PubMed ID: 7506950
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of the pseudoautosomal gene MIC2 in Ewing's sarcoma and peripheral primitive neuroectodermal tumor.
Kovar H; Dworzak M; Strehl S; Schnell E; Ambros IM; Ambros PF; Gadner H
Oncogene; 1990 Jul; 5(7):1067-70. PubMed ID: 1695726
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical profile of monoclonal antibody O13: antibody that recognizes glycoprotein p30/32MIC2 and is useful in diagnosing Ewing's sarcoma and peripheral neuroepithelioma.
Weidner N; Tjoe J
Am J Surg Pathol; 1994 May; 18(5):486-94. PubMed ID: 7513503
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibody MB2: a potential marker for Ewing's sarcoma and primitive neuroectodermal tumor.
Kahn HJ; Thorner PS
Pediatr Pathol; 1989; 9(2):153-62. PubMed ID: 2546133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
